SHAWN REID: Open Payments
NPI 1255906608 · CHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 47 payments from 17 companies in 2025. Trend: 2023 $498 · 2024 $1,382 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $242 |
| Amgen Inc. | 16 | $136 |
| PFIZER INC. | 8 | $136 |
| Phathom Pharmaceuticals, Inc. | 1 | $122 |
| Novo Nordisk Inc | 3 | $55 |
| Eisai Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $35 |
| Abbott Laboratories | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| AtriCure, Inc. | 1 | $19 |
Products named: BREZTRI, VOQUEZNA, OTEZLA, AIRSUPRA, NURTEC ODT, Leqembi, ELIQUIS, EVENITY.
Industry payments across VA — which companies pay providers there.
